Gene · 2317
Papers3,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a novel LMX1B nonsense variant associated with congenital talipes equinovarus by prenatal exome sequencing: A case report. | Mol Genet Genomic Med | 2024 | 37930140 | PubTator, text mining | PubMed |
| The exploration of mitochondrial-related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer. | Cancer Rep (Hoboken) | 2024 | 37903487 | PubTator, text mining | PubMed |
| The Genetic Landscape of Children Born Small for Gestational Age with Persistent Short Stature. | Horm Res Paediatr | 2024 | 37019085 | PubTator, text mining | PubMed |
| Rare loss-of-function variants in FLNB cause non-syndromic orofacial clefts. | J Genet Genomics | 2024 | 37003352 | PubTator, text mining | PubMed |
| Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature Review. | Pathogens | 2023 | 38276158 | PubTator, text mining | PubMed |
| Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation. | Front Immunol | 2023 | 38274824 | PubTator, text mining | PubMed |
| Utilizing multimodal mass spectrometry imaging for profiling immune cell composition and N-glycosylation across colorectal carcinoma disease progression. | Front Pharmacol | 2023 | 38273829 | PubTator, text mining | PubMed |
| Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors. | Front Pharmacol | 2023 | 38264532 | PubTator, text mining | PubMed |
| The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery. | Biomedicines | 2023 | 38255186 | PubTator, text mining | PubMed |
| Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies. | Front Immunol | 2023 | 38235128 | PubTator, text mining | PubMed |
| Physicochemical Properties of Granular and Gelatinized Lotus Rhizome Starch with Varied Proximate Compositions and Structural Characteristics. | Foods | 2023 | 38231847 | PubTator, text mining | PubMed |
| An Integrated Multi-Omics Analysis Identifying Immune Subtypes of Pancreatic Cancer. | Int J Mol Sci | 2023 | 38203311 | PubTator, text mining | PubMed |
| Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus. | Hum Vaccin Immunother | 2023 | 38172569 | PubTator, text mining | PubMed |
| Unravelling diagnostic clusters and immune landscapes of disulfidptosis patterns in gastric cancer through bioinformatic assay. | Aging (Albany NY) | 2023 | 38154092 | PubTator, text mining | PubMed |
| DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved. | Int J Mol Sci | 2023 | 38139431 | PubTator, text mining | PubMed |
| Current Status and Molecular Mechanisms of Resistance to Immunotherapy in Oral Malignant Melanoma. | Int J Mol Sci | 2023 | 38139110 | PubTator, text mining | PubMed |
| Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients. | Life (Basel) | 2023 | 38137875 | PubTator, text mining | PubMed |
| A Novel LncRNA MASCC1 Regulates the Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Sponging miR-195. | Cancers (Basel) | 2023 | 38136338 | PubTator, text mining | PubMed |
| Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients. | Oncoimmunology | 2023 | 38126027 | PubTator, text mining | PubMed |
| [Etiological analysis of a patient with multiple primary malignant neoplasms]. | Zhonghua Yi Xue Za Zhi | 2023 | 38123227 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2317/papers?page=9